questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of changes to NICE cost-effectiveness thresholds on access to medicines for rare cancers.
answerText: National Health Service patients will get improved access to life-changing treatments as a result of the changes to the National Institute of Health and Care Excellence (NICE) cost-effectiveness threshold announced in the United States and United Kingdom ...
heading: Rare Cancers: Drugs